Photodynamic therapy for prostate cancer: One urologist's perspective

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 1, 2007, Pages 26-30

  Selman, Steven H ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Photodynamic therapy; Prostate; Prostate Cancer

Indexed keywords

AMINOLEVULINIC ACID; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TEXAPHYRIN; TIN ETIOPURPURIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; FLUORESCENCE; HUMAN; LIGHT; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; TARGET ORGAN; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 33847008966     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2006.10.002     Document Type: Article

References (42)

1. Arnfield M.R., Chapman J.D., Tulip J., Fenning M.C., and McPhee M.S. Optical properties of experimental prostate tumors in vivo. Photochem Photobiol 57 2 (1993) 306-311
2. Bonnett R., White R.D., Winfield U.J., and Berenbaum M.I. Hydroporphyrins of the meso-tetra hydroxy phenyl porphyrin series as tumor photosensitizers. Biochem J 261 1 (1989) 277-280
3. Chang S.C., Buenaccorsi G., MacRobert A., and Bown S.G. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra (m-hydroxy phenyl) chlorin. Lasers Surg Med (1996)
4. Chang S.C., Buenaccorsi G.A., MacRobert A., and Bown S.G. Interstitial photodynamic therapy in the canine prostate with disulphonated aluminum phthalocyanine and 5-aminolivulinic acid induced protoporphyrin IX. Prostate 32 (1997) 89-98
5. Chen B., Pogue B.W., Hoopes P.J., and Hasan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Bio Phys 61 4 (2005) 1216-1226
6. Chen B., Zupko I., and deWitte P.A. Photodynamic therapy with hypericum in a mouse P38. Int J Oncol 18 4 (2001) 737-742
7. Chen Q., Wilson B.C., Shetty S.D., Patterson M.S., Cerny J.C., and Hetzel F.W. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res 147 (1997) 86-91
8. Dole K.C., Chen Q., Hetzel F.W., Whalen L.R., and Huang Z. Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model. Photomed Laser Surg 23 2 (2005) 172-176
9. Dougherty T.J., Lawrence G., Kaufman J.H., Boyle D.G., Wushaupt K.R., and Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 62 (1979) 231-237
10. Figge F.H.J., Weiland G.S., and Manganiello L.O.J. Cancer detection and therapy. Affinity of neoplastic and traumatized regenerating tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68 (1948) 540-641
11. Gleason D.F., and Mellinger G.T. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111 1 (1974) 58-64
12. Gross S., Gilead A., Scherz A., Neeman M., and Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med 9 10 (2003) 1327-1331
13. Henderson B.W., and Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47 (1987) 3110-3114
14. Henderson B.W., Waldow S.M., Mang T.S., and Dougherty T.S. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45 (1985) 572-576
15. Herman M.A., Fromm D., and Kessel D. Tumor blood-flow changes following protoporphyrin IX based photodynamic therapy in mice and humans. J Photochem Photobiol B 52 1-3 (1999) 99-104
16. His R.A., Kapatkin A., Strandberg J., et al. Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res 7 (2001) 651-660
17. Huang Z., Chen Q., Tmcic W., et al. Effects of Pd-bacterio pheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation. Radiat Res 161 6 (2004) 723-731
18. Jankun J., Lilge L., Dauplik A., Keck R.W., Pestka M., Szkudlarek M., Stevens P.J., Lee R.J., and Selman S.H. Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy. J Urol 172 (2004) 739-743
19. Kelly J.F., Snell M.E., and Berenbaum M.L. Photodynamic destruction of human bladder carcinoma. Br J Cancer 31 (1975) 237-244
20. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol [B] 6 (1990) 143-148
21. Lee L.K., Whitehurst C., Chen Q., Pantelides M.L., Hetzel F.W., and Moore J.V. Interstitial photodynamic therapy in the canine prostate. Br J Urol 80 (1997) 898-902
22. Lipson R.L., and Baldes E.J. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 82 (1960) 508-615
23. McNeal J.E. The prostate and prostatic urethra: a morphologic synthesis. J Urol 107 6 (1972) 1008-1016
24. McPhee M.S., Thorndyke C.W., Thomas G., Tulip J., Chapman J.D., and Lahey W.H. Interstitial applications of laser irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate cancers. Lasers Surg Med 4 (1984) 93-95
25. Morgan A.R., Rampersaud A., Garbo G.M., Keck R.W., and Selman S.H. New sensitizers for photodynamic therapy: controlled synthesis of purpurins and their effect on normal tissue. J Med Chem 32 (1989) 904-908
26. Movas B., Chapman J.D., Horwitz E.M., et al. Hypoxic regions exist in human prostate carcinoma. Urology 53 (1999) 11-18
27. Nathan T.R., Whitlaw D.E., Chang S.C., et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 168 October (2002) 1427-1432
28. Onik G. Image-guided prostate cryosurgery: state of the art. Cancer Control 8 6 (2001) 522-531
29. Pantelides M.L., Whitehurst C., Moore J.V., King T.A., and Blackhoch N.J. Photodynamic therapy for localized prostatic cancer: light penetration in human prostatic gland. J Urol 143 (1990) 398
30. Rebillard X., Gelet A., Darin J.L., et al. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. J Endourol 19 6 (2005) 693-701
31. Schreiber S., Gross S., Brandis A., et al. Local photodynamic therapy (PDT) of rat (6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of annual cure compared to surgery. Int J Cancer 99 2 (2002) 279-285
32. Selman S.H., Albrecht D., Keck R.W., Brennan P., and Kondo S. Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate. J Urol 165 (2001) 1795-1801
33. Selman S.H., Keck R.W., and Hampton J.A. Transperineal photodynamic ablation of the canine prostate. J Urol 156 (1996) 258-260
34. Selman S.H., Kreimer-Birnbaum M., Klaunig J.E., Goldblatt P.J., Keck R.W., and Britton S.L. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 44 (1984) 1924-1927
35. Star W.M., Marijnissen P.A., van der Berg-Bok A.E., Verstug J.A., Franken K.A.P., and Reinhold H.S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in-vivo in sandwich observation chambers. Cancer Res 46 (1986) 2532-2540
36. van den Boogert J., van Staveron H.J., de Bruin R.W., Siersema P.D., and van Hillegersberg R. Fractionated illumination for esophageal ALA-PDT: effect on blood flow and Pp II formation. Lasers Med Surg 16 1 (2001) 16-25
37. Weersink R.A., Bogaards A., Gutner M., et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol B 79 3 (2005) 211-222
38. Whitehurst C., Pantelides M.L., Moore J.V., Brooman P.J.C., and Blackloch N.J. In vivo laser light distribution in human prostatic carcinoma. J Urol 151 (1994) 1411-1415
39. Windahl T., Anderson S.O., and Lofgren L. Photodynamic therapy of localized prostate cancer. Lancet 336 (1990) 1139
40. Young S.W., Woodburn K.W., Wright M., et al. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem Photobiol 63 (1996) 892-897
41. Zaak D., Stohn R., and Hoeppner M. Photodynamic therapy by means of 5-ALA induced PPIX in human prostate cancer: preliminary results. Med Laser Appl 18 (2003) 17-21
42. Zhu T.C., Finlay J.C., and Hahn S.M. Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium mediated photodynamic therapy. J Photochem Photobiol B: Biol 79 (2005) 231-241